Study of the association between -403G/A and -28C/G RANTES gene polymorphisms and asthma in Lebanon
Related Experiment Video
Updated: May 24, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Rana Nahas1, Hana M Fakhoury, Hania N Chmaisse
1Department of Pharmacology, Faculty of Pharmacy, Beirut Arab University, Riyadh, Saudi Arabia.
Context:
Asthma is a complex inflammatory condition often associated with bronchial hyper reactivity and atopy. Genetic and environmental factors are implicated in the etiopathogenesis of asthma. Regulated upon Activation Normal T- cell Expressed and Secreted (RANTES) is a CC chemokine responsible for the recruitment of inflammatory cells, suggesting a possible role for this chemokine in asthma. Both -403A and -28G alleles of the RANTES promoter region were found to be associated with asthma/atopy in some but not all studies.
Aim:
The purpose of this study was to investigate the genetic influence of -403A and -28G alleles of the RANTES promoter region on the development of asthma in Lebanon.
Settings And Design:
This case control study was conducted at Makassed Hospital, Beirut on 40 asthmatic patients and 38 healthy controls.
Methods:
RANTES gene polymorphisms -403G/A and -28C/G alleles were genotyped using PCR-RFLP.
Results:
No significant differences in allele or genotype frequencies for the RANTES gene polymorphisms between asthmatic patients and controls were found. The difference of the -403 GA genotype frequency between patients and controls was not statisti-cally significant; (OR=0.8, 95% CI=0.2-2.3, P=0.8). Similarly, the difference of the A-allele frequencies between patients and con-trols was not significant (OR=0.824, CI=0.3-2.2, P=0.7).
Conclusions:
Our data show that RANTES gene promoter polymorphisms are not associated with asthma susceptibility in the Lebanese population.
Related Concept Videos
Asthma I: Introduction
Asthma-I: Introduction
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
